Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2012
09/12/2012CN102666581A Methods and compositions for the inhibition of transplant rejection
09/12/2012CN102666576A Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
09/12/2012CN102665759A Humanized antibodies against human il-22ra
09/12/2012CN102660569A Method for preparing recombinant human IgE receptor protein and application of recombinant human IgE receptor protein
09/12/2012CN102660553A Yunnan red pear [delta]PybHLH gene and prokaryotic expression vector and application thereof
09/12/2012CN102660551A VHH (variable domain of heavy chain of heavy-chain antibody) antibody gene derived from anti-CyPA (CyclophilinA) animal of family Camelidae, encoded polypeptide, and application thereof
09/12/2012CN102660509A Monoclonal antibody of evodiamine derivative, preparation method and application thereof
09/12/2012CN102659949A Anti-clenbuterol antibody and preparation method and application thereof
09/12/2012CN102659948A Antibody for resisting ractopamine and preparation method and application thereof
09/12/2012CN102659947A Novel anti-CD98 antibody
09/12/2012CN102659946A Anti-alpha v beta 6 antibodies
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102659944A IL-18 binding proteins
09/12/2012CN102659943A Antibody glycosylation in the variable region
09/12/2012CN102659942A Vibrio parahaemolyticus flagellin monoclonal antibody and antigen capture ELISA (enzyme-linked immunosorbent assay) kit
09/12/2012CN102659941A Binding molecules
09/12/2012CN102659940A 结合分子 Binding molecules
09/12/2012CN102659939A Diphenylhydantoin immunogen, diphenylhydantoin specificity-resistant antibody and diphenylhydantoin detection reagent
09/12/2012CN102659937A Preparation method and application of recombinant protein and monoclonal antibody thereof
09/12/2012CN102659929A Transient receptor potential channel-6 (TRPC6) antigen polypeptide and anti-TRPC6 monoclonal antibody
09/12/2012CN102659926A Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea
09/12/2012CN102659922A Peptide Derived From Hepatitis C Virus
09/12/2012CN102659883A DiHT-type universal hapten and artificial antigen of food radiation marker, and preparation method and application thereof
09/12/2012CN102659782A Evodiamine derivative, preparation method and application thereof
09/12/2012CN102659693A 3-methylquinoxaline-2-carboxylic acid artificial antigen and antibody obtained by the 3-methylquinoxaline-2-carboxylic acid artificial antigen
09/12/2012CN101955530B Process for extracting and purifying crucian IgM
09/12/2012CN101891815B CK19 monoclonal antibody, and preparation method and application thereof
09/12/2012CN101863970B Anti-Pf332-DBL region monoclonal antibody capable of restraining invasion of plasmodiumfalciparum
09/12/2012CN101360761B Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use
09/12/2012CN101007851B Chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
09/11/2012USRE43655 Chromatographic method for high yield purification and viral inactivation of antibodies
09/11/2012US8263749 Imatinib immunoassay
09/11/2012US8263748 Lyophilized formulations of engineered anti-IL-23p19 antibodies
09/11/2012US8263747 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/11/2012US8263746 Anti-CD38 human antibodies and uses thereof
09/11/2012US8263744 Binding proteins that bind to EpCAM linked to an effector molecule
09/11/2012US8263743 Humanized antibodies against TL1A
09/11/2012US8263741 Artificial antibody polypeptides
09/11/2012US8263738 Estrogen receptors and methods of use
09/11/2012US8263559 Feline granulocyte macrophage colony stimulating factor proteins
09/11/2012US8263412 Long wavelength engineered fluorescent proteins
09/11/2012US8263401 Adenylyl cyclase antibodies, compositions and uses thereof
09/11/2012US8263356 Antibodies and methods for predicting dental caries
09/11/2012US8263352 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263346 Nonhuman model animal lacking the ability to control lymphocyte migration
09/11/2012US8263341 Assays that detect T1R expressing cells
09/11/2012US8263326 Compounds and methods for modulating activation of NF-κB
09/11/2012US8263091 Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
09/11/2012US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2012US8263082 Chemically programmable immunity
09/11/2012US8263078 Antibodies against flagellin and uses thereof
09/11/2012US8263077 Cell growth inhibitors containing anti-glypican 3 antibody
09/11/2012US8263076 Anti-inflammatory dAb
09/11/2012US8263075 Antibody molecule for human GM-CSF receptor alpha
09/11/2012US8263074 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
09/11/2012US8263071 Protein involved in ovarian cancer
09/11/2012US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
09/11/2012CA2635352C Stabilized antibody formulation
09/11/2012CA2547032C Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies
09/11/2012CA2544920C Method for the treatment of multiple sclerosis by inhibiting il-17 activity
09/11/2012CA2510180C Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
09/11/2012CA2491864C Super humanized antibodies
09/11/2012CA2448123C Taci-immunoglobulin fusion proteins
09/11/2012CA2395291C Five-helix protein
09/11/2012CA2343839C Cytokine receptor zalpha11
09/11/2012CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
09/07/2012WO2012118813A2 Anti-il-6 receptor antibodies and methods of use
09/07/2012WO2012118547A1 Novel modulators and methods of use
09/07/2012WO2012117342A1 Depleted anti-staphylococcal enterotoxins polyclonal antibodies, preparation and uses thereof
09/07/2012WO2012117067A1 Antagonistic dr3 ligands
09/07/2012WO2012117002A1 Cea antibodies
09/07/2012WO2012116927A1 Monovalent antigen binding proteins
09/07/2012WO2012116926A1 Antigen binding proteins
09/07/2012WO2012116595A1 Tumor necrosis factor-α humanized antibody
09/07/2012WO2012116453A1 Multivalent heteromultimer scaffold design and constructs
09/07/2012WO2012096960A3 Stem cell factor inhibitor
09/07/2012WO2012092469A3 Clostridium difficile antigens
09/07/2012WO2012088290A3 Tri-variable domain binding proteins and uses thereof
09/07/2012WO2012072731A3 Improved anti-serum albumin binding single variable domains
09/07/2012WO2012047427A3 Antibodies for botulinum neurotoxins
09/07/2012CA2829020A1 Parathyroid hormone analogs, compositions and uses thereof
09/07/2012CA2828811A1 Multivalent heteromultimer scaffold design and constructs
09/07/2012CA2828464A1 Antagonistic dr3 ligands
09/07/2012CA2828000A1 Bispecific binding agents
09/07/2012CA2827799A1 Tumor necrosis factor-a humanized antibody
09/07/2012CA2827722A1 Cea antibodies
09/07/2012CA2827581A1 Anti-il-6 receptor antibodies and methods of use
09/07/2012CA2825081A1 Antigen binding proteins
09/07/2012CA2824824A1 Monovalent antigen binding proteins
09/07/2012CA2820885A1 Novel modulators and methods of use
09/06/2012US20120227134 Plants with Increased Yield
09/06/2012US20120227120 Hydrolases, nucleic acids encoding them and methods for making and using them
09/06/2012US20120226025 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
09/06/2012US20120226024 Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereof
09/06/2012US20120226023 Cytomegalovirus surface protein complex for use in vaccines and as a drug target
09/06/2012US20120225794 Antibodies Specific to Heterodimers of Bcl-2 Family and Uses Thereof
09/06/2012US20120225482 Mammalian cx3c chemokine antibodies
09/06/2012US20120225478 Anti-amyloid beta antibodies and their use
09/06/2012US20120225442 New Markers for the Diagnosis of Celiac Disease